Results 221 to 230 of about 4,644,977 (251)

The influence of a systemic non‐steroidal anti‐inflammatory drug on growth factors and cytokines in equine plasma, solid platelet‐rich fibrin (PRF), and liquid PRF

Equine Veterinary Journal, EarlyView.
Abstract Background Platelet‐rich fibrin (PRF) is a second‐generation platelet concentrate that contains growth factors and cytokines within a fibrin matrix, allowing prolonged release and supporting its use as a regenerative therapy for corneal wound healing.
Katrina E. V. Jones, Kimberly Young, Erin Barr, Chongben Zhang, Cody McGrath, Kimberly R. Love, Brian Gilger, Michala de Linde Henriksen   +7 more
wiley   +1 more source

Anti-VEGF Therapy-Induced Accelerated Atherosclerosis: STEMI in a Young Adult. [PDF]

JACC Case Rep
Byer SH, Ravindra A, Cuskey A, Saleh Y, Staffey K, Zeitler W.   +5 more
europepmc   +1 more source

Short‐Term Outcomes of Two Interventions for Patients With Active Proliferative Diabetic Retinopathy in an Urban, Safety‐Net Hospital

Health Care Science, EarlyView.
An additional weekly resident‐run panretinal photocoagulation (PRP) clinic and implementation of a high‐risk registry and appointment system were associated with a decreased wait time from proliferative diabetic retinopathy (PDR) diagnosis to PRP, increased 3‐month PRP completion rates, decreased 3‐month loss to follow‐up, and increased ophthalmology ...
Paul S. Micevych, Abu Tahir Taha, Anika Kumar, Jay M. Stewart   +3 more
wiley   +1 more source

Intravitreal anti-VEGF therapy and risk of limb complications in individuals with diabetic eye disease. [PDF]

Diabetes Res Clin Pract
Hong AT, Luu IY, Lin F, Tan TW, Toy BC.
europepmc   +1 more source

Reconstructing Skull Base Reconstruction: The State of the Art

Head &Neck, EarlyView.
ABSTRACT Background Skull base reconstruction has continued to evolve in parallel with advances in endoscopic skull base ablation in order to accomplish the goal of restoring larger and more complicated defects between the cranial and nasal cavities while balancing morbidity, cost, and recovery.
Muhammad El Shatanofy, Zoukaa Sargi, Eric Nisenbaum   +2 more
wiley   +1 more source

NKG2D upregulation sensitizes tumors to combined anti-PD1 and anti-VEGF therapy and prevents hearing loss. [PDF]

Nat Commun
Lu S, Yin Z, Wu L, Sun Y, Chen J, Wu LMN, Oblinger JL, Blake DC, Xiu B, Landegger LD, Seist R, Ho W, Jones AP, Muzikansky A, Stankovic KM, Plotkin SR, Chang LS, Xu L.   +17 more
europepmc   +1 more source

Impact of a structured patient engagement program on treatment adherence, injection persistence, and visual outcomes in real-world anti-VEGF therapy for neovascular age-related macular degeneration. [PDF]

BMC Ophthalmol
Lan L, Lan J, Ren X, Ye B.
europepmc   +1 more source

Efficacy of Anti-VEGF therapy for different OCT Patterns in diabetic macular edema and the correlation between ellipsoid zone integrity and visual acuity. [PDF]

Sci Rep
Shi XN, Zhang QY, Ju CJ, Xu YC, Xiong ZH.   +4 more
europepmc   +1 more source

Persistent Vision Loss of Eyes Lost to Follow-Up with Diabetic Macular Edema Receiving Intravitreal Anti-VEGF Therapy. [PDF]

Ophthalmol Sci
Zhou C, Shen Y, Li S, Li Y, Zhu D, Li X, Yang X, Xu Y, Wang X, Cao N, Sun D, Zhang W, Li S, Zhang H, Lv H, Ma X, Yu H, Song Z, Zhang T, Yu X, Liu Y, Niu T, Yuan R, You Z, Liu Q, Song Y, Sun X, Zheng Z, Liu K, Xu X.   +29 more
europepmc   +1 more source

OCT-based morphological prognostic factors for structural improvement after anti-VEGF therapy in wet age-related macular degeneration. [PDF]

BMC Ophthalmol
Rao T, Yang J, Chen H, Li X.
europepmc   +1 more source